Monopar Therapeutics Quarterly Common Stock, Shares, Outstanding from Q4 2016 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Monopar Therapeutics quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2016 to Q3 2024.
  • Monopar Therapeutics Common Stock, Shares, Outstanding for the quarter ending September 30, 2024 was 3.53M shares, a 75.2% decline year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 3.53M -10.7M -75.2% Sep 30, 2024 10-Q 2024-11-08
Q2 2024 17.6M +3.7M +26.6% Jun 30, 2024 10-Q 2024-08-09
Q1 2024 17.5M +4.26M +32.2% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 2.98M -9.97M -77% Dec 31, 2023 10-Q 2024-11-08
Q3 2023 14.2M +1.34M +10.4% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 13.9M +1.2M +9.43% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 13.2M +601K +4.77% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 12.9M +348K +2.77% Dec 31, 2022 10-K 2024-03-28
Q3 2022 12.9M +265K +2.11% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 12.7M +118K +0.94% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 12.6M +50.7K +0.4% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 12.6M +1.14M +9.99% Dec 31, 2021 10-K 2023-03-23
Q3 2021 12.6M +1.14M +9.94% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 12.6M +1.85M +17.2% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 12.6M +1.95M +18.3% Mar 31, 2021 10-Q 2021-05-13
Q4 2020 11.5M +866K +8.18% Dec 31, 2020 10-K 2022-03-24
Q3 2020 11.5M +2.16M +23.3% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 10.7M +1.44M +15.5% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 10.6M +1.33M +14.3% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 10.6M +1.3M +14% Dec 31, 2019 10-K 2021-03-25
Q3 2019 9.29M 0 0% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 9.29M 0 0% Jun 30, 2019 10-Q 2019-08-08
Q1 2019 9.29M 0 0% Mar 31, 2019 10-Q 2019-05-10
Q4 2018 9.29M 0 0% Dec 31, 2018 10-K 2020-03-27
Q3 2018 9.29M Sep 30, 2018 10-Q 2018-11-09
Q2 2018 9.29M Jun 30, 2018 10-Q 2018-08-09
Q1 2018 9.29M Mar 31, 2018 10-Q 2018-05-11
Q4 2017 9.29M +9.29M Dec 31, 2017 10-K 2019-02-26
Q4 2016 0 Dec 31, 2016 10-K 2018-03-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.